Compare TSHA & LZB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TSHA | LZB |
|---|---|---|
| Founded | 2019 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Home Furnishings |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2020 | N/A |
| Metric | TSHA | LZB |
|---|---|---|
| Price | $5.04 | $39.21 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 2 |
| Target Price | $10.56 | ★ $42.50 |
| AVG Volume (30 Days) | ★ 3.4M | 481.3K |
| Earning Date | 02-25-2026 | 02-17-2026 |
| Dividend Yield | N/A | ★ 2.57% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.16 |
| Revenue | $6,310,000.00 | ★ $2,107,357,000.00 |
| Revenue This Year | N/A | $2.36 |
| Revenue Next Year | N/A | $3.57 |
| P/E Ratio | ★ N/A | $17.45 |
| Revenue Growth | N/A | ★ 1.78 |
| 52 Week Low | $1.05 | $29.03 |
| 52 Week High | $6.02 | $48.31 |
| Indicator | TSHA | LZB |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 61.55 |
| Support Level | $4.80 | $37.00 |
| Resistance Level | $5.69 | $38.09 |
| Average True Range (ATR) | 0.31 | 0.82 |
| MACD | -0.11 | -0.15 |
| Stochastic Oscillator | 18.44 | 74.50 |
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
La-Z-Boy Inc is a U.S.-based company that manufactures, distributes, and retails upholstery furniture products. It is a producer of reclining chairs and distributors of residential furniture in the U.S. The company chiefly operates in the United States but also has secondary operations in Canada and other countries. The company's reportable segments include the Wholesale segment, which manufactures and imports upholstered furniture; Retail, which sells upholstered and case goods furniture to the end consumer and corporate and others. The majority of the company's revenue is derived from its Wholesale segment.